CJC-1295 No DAC & GHRP-2 – Dual-Pathway Growth Hormone Research

This blend combines CJC-1295 without DAC, a Growth Hormone-Releasing Hormone (GHRH) analog, with GHRP-2, a synthetic Growth Hormone-Releasing Peptide. Together, they engage two distinct but complementary mechanisms to promote growth hormone release in research models.

Each vial contains 2mg of CJC-1295 (No DAC) and 2mg of GHRP-2 for synergistic peptide pathway studies.

Why Combine These Peptides?

CJC-1295 (No DAC) stimulates the pituitary via the GHRH receptor, while GHRP-2 acts via the ghrelin receptor. Research suggests combining these pathways can produce a more robust and pulsatile GH release than either compound alone.

Research Applications

• Growth hormone secretion studies
• Synergistic GHRH + GHRP pathway research
• Endocrine and pituitary function modeling
• Metabolic and body composition studies
• Anti-aging and regenerative research models

Scientific Background

CJC-1295 without DAC has a shorter half-life than its DAC counterpart, allowing for more physiologically natural GH pulse patterns in experimental setups. GHRP-2 binds to the ghrelin receptor, triggering a separate signaling cascade that complements GHRH analog action. This dual stimulation approach is widely used in experimental GH release protocols.

Chemical Profile

Type: Synthetic peptide blend
Contents: 2mg CJC-1295 No DAC + 2mg GHRP-2
Appearance: Lyophilized powder
Purity: ≥98% (HPLC)

Manufactured under strict quality guidelines for research purposes only.

Storage & Handling

Store at −20°C, protected from light and moisture. After reconstitution, refrigerate at 2–8°C and use within the recommended time frame. Avoid multiple freeze–thaw cycles.

For Research Use Only

This peptide blend is intended for in vitro laboratory research only and is not for human or veterinary use.

• GHRH – Wikipedia
• GHRP – Wikipedia
• Growth Hormone – Wikipedia